402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes | Zendy

Bahareh Rajaei | Zendy; Annina Roelofsen | Zendy; Ehsan Shokrollahi | Zendy; Bas Brinkhof | Zendy; Eleumovska | Zendy; Ronald J. van der Sluis | Zendy; Maaike Nieveen | Zendy; Marten A. Engelse | Zendy; Eelco J.P. de Koning | Zendy; Françoise Carlotti | Zendy

Open Access

402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes

Author(s) -

Bahareh Rajaei,

Annina Roelofsen,

Ehsan Shokrollahi,

Bas Brinkhof,

Eleumovska,

Ronald J. van der Sluis,

Maaike Nieveen,

Marten A. Engelse,

Eelco J.P. de Koning,

Françoise Carlotti

Publication year - 2021

Publication title -

transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.45

H-Index - 204

eISSN - 1534-6080

pISSN - 0041-1337

DOI - 10.1097/01.tp.0000804432.75585.bf

Subject(s) - pdx1 , induced pluripotent stem cell , transplantation , cell therapy , progenitor cell , stem cell , cellular differentiation , biology , microbiology and biotechnology , beta cell , directed differentiation , cancer research , immunology , insulin , medicine , embryonic stem cell , endocrinology , islet , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research